SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Recruiting · NCT07141329 · Registry updated 2025-10-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 2 | 2025-10-10 | NCT07141329 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Supernus Pharmaceuticals, Inc. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medsol Clinical Research Center | Port Charlotte | United States | 7 |